Biotricity, Inc.

Equities

BTCY

US09074H2031

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-28 EDT			5-day change	1st Jan Change
0.8997 ^USD	-2.94%		-5.29%	-21.77%

06-27	Transcript : Biotricity, Inc., Q4 2024 Earnings Call, Jun 27, 2024
06-27	Biotricity, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Biotricity, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024

June 27, 2024 at 06:12 am

Biotricity, Inc. reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was USD 12.06 million compared to USD 9.64 million a year ago. Net loss was USD 14.09 million compared to USD 18.66 million a year ago.

Basic loss per share from continuing operations was USD 1.66 compared to USD 2.256 a year ago.

Latest news about Biotricity, Inc.

Transcript : Biotricity, Inc., Q4 2024 Earnings Call, Jun 27, 2024	06-27
Biotricity, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	06-27	CI
Biotricity, Inc. announced that it has received $0.5 million in funding from Ionic Ventures, LLC	06-20	CI
Biotricity, Inc. Launches Direct-To-Consumer Heart Health Screening Service, Heartsecure, Making Heart Health Services	06-12	CI
Biotricity, Inc. announced that it has received $0.645455 million in funding	05-14	CI
Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro	04-26	CI
Top Premarket Decliners	04-19	MT
Biotricity, Inc. announced that it has received $2 million in funding	04-08	CI
Biotricity Announces Strategic Partnership for Cardiac Screenings in Patients with Co-Morbidities	04-02	CI
Biotricity, Inc. announced a financing transaction	03-24	CI
Biotricity Unveils That Improved Margins Resulted from Latest Advancements to Its Proprietary Cardiac Ai Cloud Platform and Announces Plans for Continued Expansion of Its Cardiac AI Cloud	03-12	CI
Biotricity, Inc. Solidifies It's Presence in the Healthcare Landscape	03-05	CI
Transcript : Biotricity, Inc., Q3 2024 Earnings Call, Feb 21, 2024	02-21
Biotricity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-20	CI
Biotricity Inc. Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 Billion Heartbeats	01-23	CI
HC Wainwright Downgrades Biotricity to Neutral From Buy	11-20	MT
Transcript : Biotricity, Inc., Q2 2024 Earnings Call, Nov 14, 2023	11-14
Biotricity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-14	CI
Biotricity Releases Another Groundbreaking Product: Biotres Pro	23-10-31	CI
Biotricity Files Patent for Wearable Heart Monitoring Device Bioheart	23-10-10	MT
Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart Device	23-10-10	CI
Biotricity, Inc. Announces Patent Filing for Cutting-Edge Biotres Device	23-10-03	CI
Transcript : Biotricity, Inc., Q1 2024 Earnings Call, Aug 15, 2023	23-08-15
Biotricity, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Biotricity Expands Amazon, Google Partnership for Remote Cardiac Monitoring Technology	23-07-25	MT

Chart Biotricity, Inc.

Duration

Period

More charts

Company Profile

Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patientâs electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. It has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-11 - Q1 2025 Earnings Release (Projected)

More about the company